Ikonisys completes a capital increase of €150,000

Ikonisys SA, a specialist in early cancer detection, has announced a capital increase of €150,000 via a private placement. This transaction is part of an approach initiated in early 2024 to broaden its shareholder base and strengthen its financial resources.

Approved by the Board of Directors on August 14, 2024, this capital issuance allows the company to secure its working capital needs and extend its financial visibility. The new shares were issued without preferential subscription rights and on the basis of the 8th resolution of the general meeting of June 28, 2023.

With consolidated cash of €9.4K as of December 31, 2023, this transaction is in addition to several previous capital increases, totaling €1.4 million in 2024. Ikonisys now estimates that it can meet its financial needs beyond twelve months.